Skip to main content
Clinical Trials/NCT03507725
NCT03507725
Completed
Not Applicable

Improving Patient Experience and Outcomes for Men Undergoing Prostate Biopsy: A Randomized Controlled Trial With Early Stage Consent

Memorial Sloan Kettering Cancer Center1 site in 1 country390 target enrollmentApril 11, 2018
ConditionsProstate Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prostate Cancer
Sponsor
Memorial Sloan Kettering Cancer Center
Enrollment
390
Locations
1
Primary Endpoint
number of patients who sign consent form
Status
Completed
Last Updated
last year

Overview

Brief Summary

This is a study and a novel approach to clinical trials, testing the feasibility and acceptability of two-stage consent in the context of a trial integrated into routine clinical practice. The investigator will use, as a model, a trial of a brief mind-body intervention) with guided imagery for procedural pain at the time of prostate biopsy. In the two-stage design, patients will first be approached for consent to 1) have their routinely collected clinical data used for research purposes and 2) be randomly selected to be offered an intervention to improve the experience of prostate biopsy. Only patients randomized to the experimental arm will be informed about the benefits and harms of the intervention and will sign a second consent for the experimental treatment. There will be two separate randomizations in this study, one-stage (usual informed consent) vs. two-stage consent and mindfulness intervention vs. control.

Registry
clinicaltrials.gov
Start Date
April 11, 2018
End Date
October 14, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • All male patients that will be scheduled for standard prostate needle biopsy (first, repeat or active surveillance biopsy) under local anesthesia and potentially consented to the mindfulness study of mind-body intervention for prostate biopsy within the next 12 months.
  • English fluent

Exclusion Criteria

  • Patient with prior rectal surgery or anal stricture requiring surgical intervention prior to biopsy.
  • Prior prostate radiation

Outcomes

Primary Outcomes

number of patients who sign consent form

Time Frame: 2 years

Study Sites (1)

Loading locations...

Similar Trials